Get started

AI

AppLovin (APP) AnalysisCompany Overview: AppLovin NASDAQ:APP is a mobile marketing leader, providing developers with tools for user acquisition, ad optimization, and analytics. The company also benefits from its owned apps, such as Monopoly GO!, which contribute 30% of its revenue. Key Catalysts: AI-Driven Revenue Expansion 🤖 AI plays a pivotal role in AppLovin’s success, driving 80% of its revenue growth. This AI advantage helps optimize user engagement and ad targeting, boosting overall platform efficiency. Mobile Gaming Growth 🎮 The mobile gaming industry is projected to grow at an 8% annual rate through 2027, positioning AppLovin to benefit as a key player in game monetization and marketing solutions. E-Commerce Ad Expansion 🛒 AppLovin’s new e-commerce ad pilot could generate FWB:30M -$50M in Q4 2024, with a self-service platform launch in mid-2025 targeting the $200B+ global e-commerce ad market. Analyst Confidence 📊 Oppenheimer has reiterated its Outperform rating, with a $480 price target, citing AppLovin’s earnings potential, robust ad revenue streams, and growing monetization avenues. Investment Outlook: Bullish Case: We are bullish on APP above the $380.00-$400.00 range, supported by AI adoption, ad growth, and entry into e-commerce advertising. Upside Potential: Our price target is $650.00-$670.00, reflecting AppLovin’s potential to expand its revenue base across multiple high-growth sectors. 📢 AppLovin—Driving Innovation in Mobile Advertising and Game Monetization. #AppMarketing #AI #MobileGaming
NASDAQ:APPLong
by Richtv_official
China stocks ready to go? #DeepSeek another reason..This is a chart of the benchmark index for Hong Kong - HK50 It's up on Monday, while Nvidia is down 10+% If funds are flowing out of Nvidia - China (home of DeepSeek) could be one place they end up. The Hang Seng is a perfect example of how long a trend can take to reverse. How many times would traders have tried to go long this index only to see it slump right back towards the bottom? Now while this trend reversal might be delayed further - and might fail altogether - we think there is enough evidence to suggest a reversal is happening. The price is above a rising weekly 30 week SMA A long term trendline has broken Crucially - the price made a double bottom pattern around 15,000 DAILY CHART On the daily chart we see the strong surge in buying interest from September has given way to a long multi-month correction. We are looking for a breakout above the down trendline to demonstrate the correction has finished and a new up-leg is beginning. The final confirmation would come from a break of resistance (not drawn) from the November and December highs at 21,350. Should the price turn lower and make a new fractal low under 19,650 then we’ll have to wait a bit longer for the Hang Seng trend reversal. But - as always - that’s just how the team and I are seeing things, what do you think? Share your ideas with us - OR - send us a request!
PEPPERSTONE:HK50Long
by jasperlawler
$Meta and U.S equity Bull Run Almost Finished? Was just having a little fun before bed and brainstorming on the NASDAQ:META chart. Our darling as of late. I love trying to find similarities and patterns between macro swings and cycles. Human psychology and business cycles have a way of repeating themselves pretty often. As they say, history doesn't repeat, but it rhymes. This recent melt up reminds a lot of the price action NASDAQ:META saw in 2021-2022. RSI overbought both times, currently approaching the 2.618 fib when connecting them to major high and low points. Decreasing volume on the moves up. There's a lot of other data to support a bear market may be on the horizon: Weak housing data/stocks (I do see some outlier stocks in the housing sector). The yield curve un-inversion which typically precedes major bear markets 6-12 months after un-inversion. The dollar seems to want to keep going higher. However it has shown a lot of weakness here lately which could help fuel the rest of the bull market. The unwinding of the Japanese Yen carry trade has seemed to play a big factor in U.S equities as of late. Every time the BOJ hikes interest rates, a lot of U.S. equities see pretty sizable bearish volatility shortly after. Being the darling that NASDAQ:META has become, once this trend line breaks it will be a signal that everyone should be taking note of in my opinion. I think the risk of a bear market increases dramatically. Maybe we get a shallow or 2022 style bear market next year and continue to make one last lag into new highs in 2027. Here are some ideas that could support that theory: China seems to be coming out of a depression-style bear market and is beginning to inject liquidity into their economy. This could help give U.S. equities a little more juice to run higher for longer chips could make a major comeback and fuel SPY/QQQ higher for longer. Names like Google, Tesla and Amazon can continue to show strength and we could see a rotation into them. Maybe we get some more significant quantum breakthroughs with the help of AI. These are things to keep in mind, but I think the probabilities of this this bull market we've enjoyed since 2008 is A LOT closer to the end than the beginning. I base most of my sentiment off the 18.6 year real estate/land cycle theory that I have been following since 2022. I also give a lot of credibility to U.S. yield curve un-inversions sending shockwaves through the global economic system. What do you guys and gals think?
NASDAQ:META
by ChazzyFreshh
Confessions from the Desk: Nvidia is Up, I Am NotIt’s Friday, the sun is shining, and Nvidia is up. Unfortunately, I am not. Nvidia sits smugly at $137.19, while my $140 call is officially DOA—dead on arrival, with no chance of resuscitation. I’d like to say I’m surprised, but at this point, it feels like the market is just personally messing with me. To add insult to injury, my carefully curated basket of stocks has been bouncing around like a drunk day trader on margin. One minute, I think I’m up; the next, I’m refreshing my portfolio like a gambler waiting for a miracle. Spoiler alert: the miracle never comes. Meanwhile, Nvidia has been making big boy moves—cutting its stake in Arm Holdings, taking a bite out of China’s WeRide, and ghosting Serve Robotics and SoundHound AI like a bad Tinder date. The result? Stocks are moving, headlines are flashing, and somewhere in a penthouse office, a hedge fund manager is smirking at my pain. Let’s break it down: Nvidia dumps 44% of Arm Holdings – Apparently, even they have commitment issues. Exited Serve Robotics & SoundHound AI – Serve was rolling along nicely until, well... it wasn’t. SoundHound AI got the boot, too, and its shares fell 25%. Ouch. Pumped 1.7 million shares into WeRide – WeRide stock shot up 76%. That’s cool, but guess who doesn’t own WeRide? This guy. Also bet on AI cloud firm Nebius – Stock rose 8%. Lovely. Again, not in my portfolio. Now, as Nvidia makes its AI master moves, I sit here staring at my screen, watching Serve Robotics—one of my few February winners—go completely sideways. That’s right, folks. Nvidia’s got a plan, but my portfolio? It’s just vibing. But hey, it’s Friday, the sun is out, and at least I don’t own SoundHound AI. Small wins, right? Happy Friday
NASDAQ:SERV
by TwoBULLISH
3
APPLE ($AAPL) – Q1 FY25 EARNINGS & WHAT’S NEXT APPLE ( NASDAQ:AAPL ) – Q1 FY25 EARNINGS & WHAT’S NEXT (1/8) Revenue: $124.3B (+4% YoY) – A new all-time record! Services soared +14% to $26.3B, offsetting a slight dip in iPhone sales. Let’s see how Apple’s holding up. 🍎📈 (2/8) – EARNINGS BEAT • EPS: $2.40 (beat by $0.06) • Gross margin: 46.9%, topping estimates 🔥 • Despite China sales dropping 11% to $18.51B, Apple still racked up big gains elsewhere 🌏 (3/8) – SECTOR SNAPSHOT • Market cap $3.5T+, P/E ~30 • Some call it pricey vs. tech peers, but brand strength + services + potential AI expansions = possible undervaluation 🤔 • Compares favorably to Microsoft, Samsung, etc., given stable product + services synergy 🌐 (4/8) – RISKS TO WATCH • Geopolitical: China manufacturing & sales reliance → Trade tensions? Tariffs? 🏭 • Innovation Pace: Competitors could leapfrog Apple in AI or other emerging tech 💡 • Regulatory: Antitrust cases (App Store) could pinch profitability ⚖️ • Economy: Premium pricing in downturn—brand loyalty helps, but can’t ignore recession effects 💸 (5/8) – SWOT HIGHLIGHTS Strengths: Legendary brand loyalty & huge install base Growing services revenue (+14%!) Massive cash reserves for R&D & buybacks Weaknesses: Heavy dependence on iPhone sales China manufacturing concentration Opportunities: AI, AR/VR expansions (Vision Pro, maybe more) Emerging markets → untapped smartphone penetration 🌍 Services sector continuing to expand ⚡ Threats: Fierce competition (especially in China) 🦖 Trade tensions & supply chain hiccups 🌐 Shifts in consumer tech tastes or new disruptors (6/8) – CHINA SALES DENT • China down 11%—that’s a chunk given its importance • Local giants (Xiaomi, Huawei) are snapping at Apple’s heels 🦾 • Will Vision Pro + AI upgrades woo Chinese consumers back? 🤔 (7/8) – Is Apple undervalued at a $3.5T market cap & P/E of 30? 1️⃣ Bullish—Brand power + AI = unstoppable 🍀 2️⃣ Neutral—Solid, but watch those China risks 🔍 3️⃣ Bearish—Too expensive, competition’s rising 🐻 Vote below! 🗳️👇
NASDAQ:AAPLLong
by DCAChampion
1
Tempus AI Possible Partner for the Stargate Project in the USAAnalysis of Possible Surge in Tempus AI Stock Due to Project Stargate Introduction Tempus AI, Inc. has emerged as a key player in the health technology space, leveraging data science and artificial intelligence (AI) to develop precision medicine solutions. The company's focus on oncology, cardiology, and mental health, combined with its strong data-driven approach, has positioned it as a leader in the emerging field of AI-enabled healthcare. A possible surge in Tempus AI’s stock price is now being speculated, due to its potential involvement in Project Stargate, a new initiative spearheaded by President Donald Trump. Project Stargate promises significant investments and infrastructure development in AI, which could catalyze a favorable growth trajectory for Tempus. This analysis will explore the potential impact of Project Stargate on Tempus AI, considering both the direct and indirect benefits for the company. Additionally, the mention of prominent political figures like Nancy Pelosi purchasing Tempus stock adds an interesting layer to the speculative nature of this surge. --- Project Stargate Overview Project Stargate, as outlined by former President Donald Trump, aims to overhaul AI infrastructure in the U.S. The initiative seeks to foster partnerships between technology firms, including AI-focused companies like OpenAI, and businesses involved in critical infrastructure, such as data centers, power generation, and construction. The project’s goal is to drive advancements in AI technology, with a specific focus on enhancing U.S. competitiveness in this rapidly growing field. The strategic involvement of multiple high-profile organizations and the federal government indicates that Project Stargate is likely to have wide-reaching economic and technological ramifications. Key elements of the project include: -Infrastructure Investments: The construction and expansion of AI-driven data centers and related infrastructure. - Public-Private Partnerships: Strong cooperation between private companies and government entities, facilitating new technologies and business models. - Technological Advancements: AI solutions that push the boundaries of healthcare, cybersecurity, and national security. As a result, companies involved in the development and deployment of AI technology, particularly those in healthcare and data analytics, are poised to benefit significantly. --- Tempus AI’s Position in Project Stargate Tempus AI operates at the intersection of healthcare and AI, which makes it an intriguing candidate to potentially benefit from Project Stargate. The company’s focus on precision medicine using AI-driven diagnostics aligns well with the ambitions of Project Stargate to expand AI infrastructure. 1. Synergies with Healthcare AI Project Stargate is expected to fuel demand for AI infrastructure and innovations, particularly in sectors like healthcare. Tempus, which specializes in oncology, cardiology, and depression diagnostics, stands to benefit from both the increased focus on AI-powered healthcare solutions and the additional resources available through government-private sector partnerships. Given Tempus’s reliance on large-scale data analysis to build its precision medicine solutions, any acceleration in AI infrastructure could lower operational costs for Tempus while improving the capabilities of its platform. Enhanced AI infrastructure would likely lead to faster data processing, increased diagnostic accuracy, and the potential for more personalized treatments. 2. Expansion of Partnerships and Funding The potential for public-private partnerships, which Project Stargate promotes, could help Tempus secure additional government contracts or private sector collaborations. This influx of capital and resources could enable the company to scale its technology faster and expand into new medical areas beyond its current focus on cancer, cardiology, and mental health. 3. Alignment with National AI Strategy With AI being a major focus of Project Stargate, Tempus may find itself well-positioned within the broader national AI strategy. If the company becomes a key partner in helping build AI solutions for healthcare or other sectors, it could solidify its reputation as an industry leader, driving up stock demand and valuation. --- Nancy Pelosi’s Stock Purchase: A Political Angle The mention of Nancy Pelosi, a prominent U.S. politician, purchasing Tempus AI stock adds a speculative element to the situation. Pelosi’s involvement in the stock could be seen as a potential signal of confidence in Tempus AI’s future performance. Politicians often make investment decisions based on inside knowledge of forthcoming legislation, partnerships, or government contracts. Though speculation about Pelosi’s investment could generate increased media attention, it should be approached with caution. However, if Pelosi’s investment is tied to a potential announcement of government support or strategic alignment between Tempus and Project Stargate, it could amplify investor confidence and trigger a buying frenzy. --- Potential Catalysts for Stock Surge Several factors could drive a surge in Tempus AI’s stock price if Project Stargate moves forward: -1. Government Contracts and Funding: If Tempus is awarded government contracts under Project Stargate, particularly related to AI infrastructure or healthcare solutions, the company could see a significant increase in revenue and market capitalization. -2. Partnerships with Major Players: Any announcement of Tempus AI partnering with companies like OpenAI or other stakeholders in Project Stargate would likely signal strong growth potential and increase investor interest. -3. ncreased Demand for AI Healthcare Solutions**: As the U.S. government prioritizes AI advancements, healthcare applications could see substantial growth. Tempus could be a key beneficiary of this shift, leading to a surge in its stock price as market expectations align with actual developments. -4. Political Endorsement: If high-profile political figures continue to signal support for Tempus AI, either through public statements or stock purchases, it could bolster public perception and attract institutional investors. --- Risks and Considerations While there is substantial upside potential for Tempus AI, there are also risks to consider: - Dependence on Project Stargate’s Success: Tempus’s growth will be closely tied to the success of Project Stargate and its integration into the broader national AI ecosystem. If the project faces delays or fails to meet expectations, it could have negative implications for companies like Tempus. - Regulatory Risks: The healthcare industry is heavily regulated, and any change in regulatory policies could impact Tempus’s ability to grow at the expected pace. While AI infrastructure investment may mitigate some challenges, government policies could still create obstacles. - Market Volatility: The stock market, particularly tech and healthcare stocks, is inherently volatile. Any unforeseen global events or shifts in economic conditions could negatively affect Tempus’s valuation, regardless of Project Stargate. --- Conclusion Tempus AI stands at an exciting intersection of AI technology and healthcare, which could see its stock price surge due to its involvement in Project Stargate. The initiative’s focus on building AI infrastructure and fostering partnerships could provide Tempus with opportunities for rapid growth, enhanced funding, and access to cutting-edge technology. The involvement of high-profile political figures such as Nancy Pelosi adds an additional layer of speculation, with the potential for both public perception and market sentiment to play a significant role in the stock’s trajectory. However, investors should consider the risks associated with regulatory changes, market volatility, and the uncertain success of Project Stargate itself. Ultimately, if Tempus AI is able to capitalize on these emerging opportunities, it could see a substantial boost in both market visibility and stock price in the near future. For any questions or remarks kindly react here under the comments Greetings, Zila
NASDAQ:TEMLong
by ZILATRADES
11
Arista Into EarningsANET is still suffering from the NVDA sell off (I would argue completely irrational panic). It's currently ranging right in the middle of major support and major resistance. So it's tricky because we're so far above support, but also lots of room to recover losses. My bet into earnings is Arista breaks above resistance at $141. Arista is trading just under 20X revenue and they have amazing profit margins and sustained growth. The broader Nasdaq Computer Index IXCO is very close to breaking out of this long range it's been so it seems like a fair bet that ANET jumps to the upside along with everything else. Good Luck!
NYSE:ANETLong
by bwy
7
FRESHWORKS ($FRSH): DRIVING AI-POWERED GROWTH IN SaaSFRESHWORKS ( NASDAQ:FRSH ): DRIVING AI-POWERED GROWTH IN SaaS 1/7 Revenue Growth: Freshworks just posted $194.6M in Q4 2024 (+22% YoY), with full-year revenue hitting $ 720M (+21% YoY)! ⚡️ Growth is fueled by new customer wins and the rising AI demand in customer service, sales, and IT solutions. 2/7 – EARNINGS BEAT • Non-GAAP EPS: $0.14 (beat by $0.04) 💰 • Operating profit for FY2024 doubled to $ 99M from $ 44.5M in 2023 🔥 • FY2025 guidance: Revenue $ 809M–$ 821M (12–14% YoY growth) 🚀 3/7 – CASH FLOW & PROFITABILITY • Free Cash Flow margin at 21% in Q4—showing major profitability strides 💸 • Shifting from less profitable past to a more robust, scalable business model 🏆 4/7 – SECTOR SNAPSHOT • Competes with Salesforce, HubSpot, Zendesk in the SaaS arena 🌐 • Enterprise Value to Revenue ratio is on the lower end—could be undervalued given its growth 📈 • Mid-market & SMB focus → niche advantage vs. pricier enterprise solutions 5/7 – RISK FACTORS • Market Competition: Big fish (Salesforce) + fresh entrants (Zendesk) 🏦 • Customer Acquisition: High marketing costs, must maintain ROI 🤝 • Economic Sensitivity: Downturn = possible budget cuts on software 💼 • Tech Shifts: Rapid AI innovation—no resting on laurels! 🤖 6/7 – SWOT HIGHLIGHTS Strengths: • Strong AI-driven revenue growth • Wide product portfolio (sales, IT, support, etc.) • Growing customer base & retention ✅ Weaknesses: • Less profitable historically (though improving) • Revenue heavily reliant on core products 😬 Opportunities: • Expand into untapped global markets • Double down on AI for new revenue streams 🌍 Threats: • Market saturation & intense competition 🏁 • Data privacy regs could disrupt operations ⚖️ 7/7 Freshworks: undervalued gem or just another SaaS player? 1️⃣ Bullish—AI + mid-market niche = unstoppable! 🏅 2️⃣ Neutral—Need more proof of profitability 🤔 3️⃣ Bearish—Competition & economy hold it back 🐻 Vote below! 🗳️👇
NASDAQ:FRSHLong
by DCAChampion
2
UPSTART ($UPST): AI-DRIVEN LENDING ON THE RISEUPSTART ( NASDAQ:UPST ): AI-DRIVEN LENDING ON THE RISE 1/8 – REVENUE & EARNINGS BLAST • Q4 2024 revenue: $219M (+56% YoY) 🔥 • Powered by a 68% jump in loan originations 💸 • EPS: $0.26, beating estimates by $0.30 (analysts expected -$0.04) 🚀 • Positive Adj. EBITDA—Upstart’s inching closer to sustained profitability 🏆 2/8 – BIG FINANCIAL EVENTS • Strong focus on AI model innovation + expanding funding supply 🤖 • Management bullish on earnings call—AI improvements = growth catalyst 🚀 • Renowned for bridging lenders & borrowers via advanced, automated credit assessments 🌐 3/8 – SECTOR COMPARISON • Some valuation measures say overvalued (e.g., GF Value ~$28 vs. market ~$65) 🧐 • Outpacing fintech peers like SoFi, PayPal, Ally in revenue growth 📈 • Profitability & multiples (P/E, P/S) lag behind due to recent net losses 😬 • Unique AI-lending angle may justify a premium—if it pays off 💡 4/8 – RISK ASSESSMENT • Partner Dependence: A few big lenders = high exposure ⚠️ • Economic Sensitivity: Loan defaults rise if consumer conditions worsen 🌪️ • Regulatory Hurdles: Shifting financial rules could dent operations 🏛️ • Credit Risk: Holding loans on the balance sheet—watch out in downturns 💥 5/8 – SWOT HIGHLIGHTS Strengths: • Advanced AI for credit analysis 🤖 • High automation in approvals ⚡️ • Scalable via partner expansions 🌍 Weaknesses: • Limited operating history ⏳ • Recent financial losses 📉 • Reliance on key partners 🤝 Opportunities: • New loan products (auto, HELOC, etc.) 🚗🏠 • Expanding digital lending market 🌐 • Gaining market share as AI evolves 🔬 Threats: • Fierce fintech competition 🏁 • Possible regulatory changes ⚖️ • Macro headwinds affecting credit demand 🌩️ 6/8 – UN/UNDERVALUATION DEBATE • Some see big future potential → undervalued by growth prospects 💹 • Others worry about multiples & an over-reliance on economic upswings 😬 • Recovery depends on broader economic rebound & strong risk management 🏦 7/8 Is Upstart a gem or a risk? 1️⃣ Bullish—AI lending will transform fintech 🏅 2️⃣ Cautiously Optimistic—Need more stability 🤔 3️⃣ Bearish—Valuation & macro risks are too high 🚫 Vote below! 🗳️👇 8/8 – STRATEGY WATCH • Keep tabs on new loan products & partnerships 🛠️ • Monitor economic indicators (defaults, credit demand) impacting revenue 💼 • Regulatory shifts can either boost or bury AI-lending advantage ⚠️
NASDAQ:UPSTLong
by DCAChampion
1
$AMD position trade idea LONG TERM weekly/monthlyNASDAQ:AMD has been weak for awhile on the weekly chart, but nothing lasts forever. This is a long position trade idea I have for myself, with the thesis that, long term, NASDAQ:AMD is reaching for $360ish over the next couple of years, based on fib projections from back when the bull market started years ago. NASDAQ:AMD briefly touched a premium zone months ago (red shaded area), and with the current weakness NASDAQ:AMD has been pulling back and just reached a short term discount zone around $109 (green shaded area). My expectation is that NASDAQ:AMD might drop a bit more into this zone, perhaps sweep under the lows at $93.12, reach a couple of projected targets for the short interest (that I have marked in red and orange lines), and then find support and bounce aggressively from there. This is all based on a pattern I frequently see where when a chart reaches the premium zone near the end of a move, it often pauses just shy of the target and feigns a reversal, falling back into the short term discount zone, often sweeping a low, and then aggressively pushing for the target that was intended all along. This serves to wash out any short term holders and deny them the full target, while offering good prices to the long term holders to reaccumulate before reaching their target. Seek professional investment advice elsewhere, this is not trading or investment advice, this is my own observations and how I intend to approach NASDAQ:AMD in this current price area. I will not be blindly buying anything and I always manage my risk in case I'm wrong.
NASDAQ:AMDLong
by easycators
5
STOCKS | AI | Amazon, Meta & MSFTPeople who are saying that AI is just a bubble are missing the big picture. Huge tech companies are pouring serious money into it, which shows they believe AI is here to stay. We're talking massive investments – like over $320 billion in AI infrastructure by 2025, according to the Financial Times. Amazon is planning over $100 billion in capital expenditures in 2025, mainly focused on AI infrastructure. This could be huge not only for NASDAQ:AMZN as a whole but also for the AI industry. Alphabet is also throwing in around $75 billion this year to boost its AI capabilities. These kinds of investments from the top players make it clear: they know you have to spend big to win in the AI game and clearly there is a race going on, especially after the release of DeepSeekAI. American companies don't want to be left behind, and it's likely that they will pour money into integrating AI to improve their business operation - with the ultimate aim to improve profit - which is great for stock prices. How they make money from AI might change over time, but the overall direction is obvious – AI is changing everything and driving innovation. According to Statista, the global AI market is predicted to reach around $826 billion by 2030. That kind of growth tells you AI is going to be a major force in just about every industry. And therefore I believe that all the companies making major investment in AI will also see exponential growth over the next 5 years - meaning it may be a longer term game play. _______________ NASDAQ:MSFT NASDAQ:META
NASDAQ:MSFTLong
by CryptoCheck-
2
$SMCI (SUPER MICRO COMPUTER): AI-DRIVEN GROWTH AMID GOVERNANCESMCI (SUPER MICRO COMPUTER): AI-DRIVEN GROWTH AMID GOVERNANCE WOES 1/8 Super Micro Computer ( NASDAQ:SMCI ) just revealed prelim Q2 FY2025 sales of $5.6–5.7B (+54% YoY), riding AI’s wave. But delayed filings & margin pressure spark caution. Let’s dig in! 💻⚡️ 2/8 – REVENUE & EARNINGS SNAPSHOT • Q2 sales: $5.7B (vs. $5.9B est.), EPS: ~$0.59 (est. $0.64) • Full-year outlook trimmed to $23.5–25B (was $26–30B) • Non-GAAP gross margin: ~11.9%; operating margin: ~7.9%—still under pressure 🏭 3/8 – KEY FINANCIAL EVENTS • $700M in 2.25% convertible senior notes → fueling AI server growth • Filing delays (10-K, 10-Qs) → must meet Feb 25, 2025 to avoid Nasdaq delisting • New auditor BDO checks the books—no fraud found, but concerns linger about governance 🧐 4/8 – GOVERNANCE & INVESTIGATIONS • Ongoing SEC & DOJ probes after Hindenburg’s short-seller report • CEO says they’ll meet filing deadline, but trust is still shaky • Market watchers: “No fraud found” is good, but the uncertainty stings 🤔 5/8 – SECTOR CONTEXT • Competes with Dell ( NYSE:DELL ), HPE ( NYSE:HPE )—both see AI demand, but SMCI more focused • SMCI trades at ~11x 2025 earnings (vs. Dell at 15x, HPE at 12x) • Could be undervalued—but only if governance issues don’t overshadow the AI growth story 🚀 6/8 – RISKS • Margin Pressure: R&D + product mix + potential GPU shipment delays (Nvidia Blackwell) • Debt Load: Total debt now ~$1.9B, plus $700M in convertible notes • Regulatory Overhang: Missing that Feb 25 deadline = serious delisting risk ⚠️ 7/8 Is SMCI worth the gamble? 1️⃣ Bullish—AI potential outweighs the risks 2️⃣ Neutral—Need clarity on filings & margins 3️⃣ Bearish—Governance red flags trump growth Vote below! 🗳️👇 8/8 – STRATEGIC OUTLOOK • 70%+ revenue from AI platforms → big edge if servers remain hot • Partnerships w/ Nvidia & push into liquid-cooled data centers • Delaying or messing up compliance could sabotage all that potential 🌐
NASDAQ:SMCILong
by DCAChampion
1
NVIDIA Price Rebalance to 132$You most likely already know that most retail traders lose money. With the fear of new cost efficient AI news most people shorted NVIDIA. Whatever the name of the AI and whichever the country it is and however efficient it is, it will still run on hardware and as of now NVIDIA is the biggest hardware maker. This is the chance to buy since price did not go down in a healthy price action. We expect a recovery to equilibrium of the inefficient drop of price at 132$ Please comment any questions you have. Happy and safe trading!
NASDAQ:NVDALong
by TradeConfirmed
4
iotex is best depin projectIoTeX (IOTX) has recently garnered significant attention in the cryptocurrency market, particularly following a substantial $50 million investment from a consortium of venture capital firms. This infusion of capital is poised to accelerate the growth and adoption of Decentralized Physical Infrastructure Networks (DePIN), positioning IoTeX for a promising future. citeturn0search14 **Strategic Investments and Partnerships** The recent $50 million funding round, led by prominent investors such as Borderless Capital and Amber Group, underscores the confidence in IoTeX's vision and technological capabilities. These strategic partnerships are expected to enhance IoTeX's infrastructure and expand its ecosystem, fostering increased adoption and utility of the IOTX token. citeturn0search2 **Market Performance and Future Projections** As of now, IOTX is trading at approximately $0.0201, with a 24-hour trading volume of around $9.49 million. The token has experienced a slight decline of 1.68% in the past day. Looking ahead, various analyses offer optimistic projections for IOTX. For instance, CoinCodex forecasts that IoTeX could reach a high of $0.2922 by 2025, representing a potential increase of over 1,350% from its current price. citeturn0search1 Similarly, DigitalCoinPrice anticipates that IOTX may reach $0.068 by 2025 and $0.16 by 2030, indicating sustained growth over the long term. The substantial venture capital investment, coupled with strategic partnerships and favorable market projections, suggests a promising trajectory for IoTeX. As the platform continues to develop and expand its DePIN initiatives, the value of IOTX is well-positioned for significant appreciation in the coming years. *Note: This analysis is based on information available as of February 10, 2025. Investors are advised to conduct their own research and consider market dynamics before making investment decisions.*
Long
by mehdikebrititrader
Shopify (SHOP) AnalysisCompany Overview: Shopify NYSE:SHOP is a leading e-commerce platform that continues to grow by expanding into AI-driven solutions and fulfillment services, aiming to optimize merchant growth. Shopify is positioning itself as a major player in the e-commerce ecosystem, particularly with Shopify Plus, which is gaining momentum among large retailers. Key Catalysts: AI-Powered Tools for Merchants 🤖 Shopify is integrating AI-driven solutions to enhance marketing, inventory management, and checkout optimization, which improves merchant retention and adoption. Enterprise Growth 📈 Shopify Plus is experiencing strong adoption among larger retailers, helping diversify revenue and reduce the company's reliance on small businesses. This supports more stable growth. Long-Term E-commerce Growth 🌐 With e-commerce projected to grow at a 9.5% CAGR through 2030, Shopify holds a 10% market share in the U.S., positioning it for long-term growth in an expanding digital marketplace. Financial Strength 💰 Free cash flow margin rose to 19%, underscoring Shopify’s robust financial health and ability to reinvest in future growth initiatives. Investment Outlook: Bullish Case: We are bullish on SHOP above the $102.00-$105.00 range, driven by AI expansion, growing enterprise adoption, and strong cash flow. Upside Potential: Our price target is $170.00-$172.00, reflecting the company’s dominance in e-commerce and its ongoing innovations. 📢 Shopify—Shaping the Future of E-Commerce and AI. #Ecommerce #AIExpansion #SHOP
NYSE:SHOPLong
by Richtv_official
NVIDIA (NVDA) Bounces Off Weekly EMA – Is a Rally Coming?📈 NVIDIA (NVDA) closed the week with a strong bullish candle, rebounding off the 50-week EMA. Historically, this has been a key level for the stock, often signaling strong continuation moves to the upside. Key Observations: - 1W 50 EMA Support: In previous cycles, NVDA has repeatedly touched this moving average and rebounded, leading to sustained uptrends. The highlighted regions on the chart reinforce this pattern. - Strong Buying Volume: The volume bars suggest renewed interest from buyers at this level. - Macro Uptrend Intact: Despite recent corrections, NVDA remains in a long-term bullish trend. Fundamentals: - NVIDIA is expected to release their next earnings report on February 26th, which is in 19 days from now. - NVIDIA is set to release their $3000 NVIDIA GB10 compact AI super computer in May. - As cheaper-to-run AI models like DeepSeek are released and get into the hands of businesses, this will lead to increased demand for AI chips (read about Jevons' Paradox on Wikipedia ). Potential Price Path: 🚀 If history repeats, this bounce could lead NVDA to reclaim previous highs and even explore new all-time highs in the coming months. ⚠️ Risk Factor: If NVDA fails to hold above the 50-week EMA, downside risk increases, with a potential retest of lower support levels. 📊 Conclusion: This historical pattern suggests a high-probability trade setup. Traders and investors should keep an eye on volume confirmation and macroeconomic conditions before making their next move. 💬 What’s your take on NVDA’s next move? Share your thoughts below! 👇 Let me know if you want any refinements or additional insights. 🚀 Don't forget, Patience is Paramount.
NASDAQ:NVDALong
by PatienceIsParamount
1
Breaking: Doximity Stock Jumps 37% On Upbeat Annual OutlookDoximity Inc. (NASDAQ: DOCS), the leading digital platform for U.S. medical professionals, has made headlines with its stock skyrocketing 37% following a stellar earnings report and an upbeat annual outlook. The company’s third-quarter fiscal 2025 results not only surpassed analyst expectations but also showcased robust growth in key areas, including AI tools and user engagement. Strong Earnings and Upbeat Guidance Doximity’s latest earnings report has solidified its position as a growth powerhouse in the healthcare technology sector. Here are the key highlights: 1. Record Revenue and Earnings Growth - Revenue: $168.6 million, up 25% year-over-year, beating consensus estimates of $152.82 million. - Earnings Per Share (EPS): Adjusted EPS of $0.45, a significant jump from $0.29 a year ago and well above the $0.34 consensus. - Net Income: $75.2 million, up 57% year-over-year, reflecting strong profitability. 2. AI Tools and User Engagement Driving Growth Doximity’s AI-powered tools saw a 60% quarter-over-quarter increase in usage, while its newsfeed surpassed one million unique providers. This demonstrates the platform’s ability to innovate and retain user engagement, which is critical for long-term growth. 3. Raised Guidance for Fiscal 2025 The company raised its revenue guidance to $564.6 million—$565.6 million, up from the previous range of $535 million—$540 million. Adjusted EBITDA guidance was also increased to $306.6 million—$307.6 million, signaling confidence in continued profitability and operational efficiency. 4. Analyst Optimism Analysts have responded positively to Doximity’s performance: - Needham: Raised price target from $65 to $82, maintaining a Buy rating. - Wells Fargo: Increased price target from $43 to $55, maintaining an Equal-Weight rating. - Raymond James: Raised price target from $65 to $83, reiterating an Outperform rating. These upward revisions reflect growing confidence in Doximity’s ability to sustain its momentum. Technical Analysis: From a technical perspective, NYSE:DOCS is exhibiting a classic gap-up pattern, with shares up 35.68% at the time of writing. Here’s what the charts are telling us: 1. Gap-Up Pattern The gap-up indicates a surge in buying interest following the earnings announcement. While this is a bullish signal, gaps are often filled in the long run, meaning the stock could retrace some of its gains before continuing its upward trajectory. 2. The Relative Strength Index (RSI) is currently at 86, well above the overbought threshold of 70. This suggests that the stock may be due for a short-term pullback or consolidation as traders take profits. 3. Despite overbought conditions, the stock’s momentum remains strong. Key support levels to watch include the pre-gap price zone around $61. A pullback to this area could present a buying opportunity for investors looking to enter at a lower price. Why Doximity Stands Out Doximity’s success is rooted in its ability to address critical needs in the healthcare industry. Its digital platform streamlines communication and workflow for medical professionals, while its AI tools enhance efficiency and decision-making. With over 610,000 unique providers using its clinical workflow tools, Doximity has established itself as an indispensable resource for healthcare professionals. A Strong Buy with Caution Doximity’s impressive earnings report and raised guidance have rightfully propelled its stock to new heights. From a fundamental perspective, the company’s growth trajectory, driven by AI innovation and user engagement, is compelling. Technically, while the stock is overbought in the short term, the long-term outlook remains bullish.
NYSE:DOCSLong
by DEXWireNews